Retail-Drug Stores and Proprietary Stores
Standard Industrial Classification: SIC 5912
Industry Insider Sentiment Analysis
The Retail-Drug Stores and Proprietary Stores sector (SIC 5912) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-02 00:43 | 2024-09-27 | GRDN | Guardian Pharmacy Services, Inc. | COSLER STEVEN D | Director | BUY | $14.00 | 7,142 | $99,988 | 7,142 |
| 2024-10-02 00:43 | 2024-09-27 | GRDN | Guardian Pharmacy Services, Inc. | LEWIS RANDALL J | Director | BUY | $14.00 | 3,571 | $49,994 | 3,571 |
| 2024-08-20 00:05 | 2024-08-15 | PETS | PETMED EXPRESS INC | Smith Jacqueline Paula | SELL | $3.19 | 601 | $1,917 | 20,099 | |
| 2024-05-02 23:30 | 2024-05-02 | CVS | CVS HEALTH Corp | Mahoney Michael F | Director | BUY | $54.49 | 9,181 | $500,294 | 9,356 |
| 2024-05-02 23:31 | 2024-05-02 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | BUY | $53.88 | 1,000 | $53,879 | 21,630 |
| 2024-02-17 02:46 | 2024-02-16 | CVS | CVS HEALTH Corp | Shah Prem S | Officer | SELL | $76.95 | 29,473 | $2,267,947 | 39,765 |
| 2023-11-13 19:52 | 2023-11-09 | PETS | PETMED EXPRESS INC | FULGONI GIAN | Director | BUY | $7.34 | 41,000 | $301,125 | 109,510 |
| 2023-11-07 22:17 | 2023-11-03 | PETS | PETMED EXPRESS INC | Hulett Mathew N | Director, Officer | BUY | $7.26 | 13,850 | $100,551 | 613,850 |
| 2023-11-07 22:10 | 2023-11-03 | PETS | PETMED EXPRESS INC | Chambers Christine | Officer | BUY | $7.26 | 6,888 | $50,007 | 19,888 |
| 2023-11-06 18:59 | 2023-11-03 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | BUY | $70.47 | 2,000 | $140,930 | 20,630 |
| 2023-08-05 00:41 | 2023-08-03 | CVS | CVS HEALTH Corp | Clark James David | Officer | SELL | $74.92 | 25,759 | $1,930,004 | 4,698 |
| 2023-05-05 15:27 | 2023-05-03 | CVS | CVS HEALTH Corp | Lynch Karen S | Director, Officer | BUY | $69.75 | 14,000 | $976,567 | 431,392 |
| 2022-12-17 00:14 | 2022-12-15 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer | OPT+S | $98.36 | 137,466 | $13,521,183 | 608,129 |
| 2022-08-05 23:48 | 2022-08-03 | CVS | CVS HEALTH Corp | Finke Daniel P | Officer | OPT+S | $100.00 | 9,546 | $954,600 | 32,150 |
| 2022-08-05 23:50 | 2022-08-03 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer | OPT+S | $98.94 | 143,440 | $14,192,370 | 109,183 |
| 2022-07-01 00:00 | 2022-06-28 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer | OPT+S | $95.00 | 138,654 | $13,172,130 | 626,273 |
| 2022-04-12 23:51 | 2022-04-08 | CVS | CVS HEALTH Corp | Shah Prem S | Officer | OPT+S | $105.00 | 16,954 | $1,780,170 | 43,453 |
| 2022-04-07 00:02 | 2022-04-04 | CVS | CVS HEALTH Corp | Finke Daniel P | Officer | OPT+S | $100.12 | 61,300 | $6,137,197 | 32,150 |
| 2022-03-31 23:49 | 2022-03-30 | CVS | CVS HEALTH Corp | Shah Prem S | Officer | OPT+S | $104.70 | 5,346 | $559,726 | 59,071 |
| 2022-03-18 23:55 | 2022-03-17 | CVS | CVS HEALTH Corp | Shah Prem S | Officer | OPT+S | $106.65 | 4,624 | $493,150 | 59,071 |
| 2022-03-17 23:32 | 2022-03-15 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer | OPT+S | $105.00 | 51,361 | $5,392,905 | 836,751 |
| 2022-02-12 00:42 | 2022-02-10 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | BUY | $105.90 | 1,000 | $105,904 | 18,334 |
| 2022-02-05 00:46 | 2022-02-03 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer | OPT+S | $110.00 | 47,937 | $5,273,070 | 138,246 |
| 2022-02-03 00:20 | 2022-02-01 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer | OPT+S | $106.50 | 21,386 | $2,277,566 | 61,341 |
| 2022-02-02 00:43 | 2022-01-28 | CVS | CVS HEALTH Corp | Clark James David | Officer | OPT+S | $109.00 | 6,059 | $660,431 | 17,497 |
| 2022-01-29 00:58 | 2022-01-27 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer | OPT+S | $107.50 | 68,482 | $7,361,815 | 107,115 |
| 2021-11-05 23:35 | 2021-11-03 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer | OPT+S | $95.00 | 108,870 | $10,342,650 | 107,115 |
| 2021-11-03 23:44 | 2021-11-01 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer | OPT+S | $90.00 | 28,159 | $2,534,310 | 138,246 |
| 2021-10-28 23:34 | 2021-10-26 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer | OPT+S | $88.00 | 82,757 | $7,282,616 | 138,246 |
| 2021-09-08 02:57 | 2021-09-02 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer | SELL | $87.00 | 2,625 | $228,375 | 140,201 |
| 2021-08-05 23:58 | 2021-08-05 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | BUY | $79.55 | 3,000 | $238,635 | 17,334 |
| 2021-06-30 00:43 | 2021-06-28 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer | SELL | $83.67 | 2,781 | $232,686 | 61,048 |
| 2021-06-18 00:04 | 2021-06-15 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer | OPT+S | $86.00 | 67,552 | $5,809,472 | 142,826 |
| 2021-06-08 23:48 | 2021-06-07 | CVS | CVS HEALTH Corp | Finke Daniel P | Officer | OPT+S | $86.60 | 37,594 | $3,255,640 | 23,310 |
| 2021-06-04 18:56 | 2021-06-02 | PETS | PETMED EXPRESS INC | ROSENBLOOM BRUCE S | Officer | SELL | $42.50 | 6,000 | $255,000 | 30,525 |
| 2021-05-13 00:30 | 2021-05-10 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer | OPT+S | $86.00 | 109,469 | $9,414,334 | 0 |
| 2021-05-11 00:18 | 2021-05-07 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer | SELL | $84.00 | 9,477 | $796,068 | 144,697 |
| 2021-05-07 00:52 | 2021-05-04 | CVS | CVS HEALTH Corp | Boratto Eva C | Officer | SELL | $80.00 | 4,905 | $392,400 | 115,331 |
| 2021-04-23 23:57 | 2021-04-21 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer | OPT+S | $77.00 | 103,423 | $7,963,571 | 0 |
| 2021-04-02 00:31 | 2021-03-31 | CVS | CVS HEALTH Corp | Clark James David | Officer | OPT+S | $76.00 | 5,350 | $406,600 | 7,244 |
| 2021-03-31 00:01 | 2021-03-29 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer | OPT+S | $76.15 | 62,943 | $4,793,109 | 0 |
| 2021-03-30 01:55 | 2021-03-26 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer | OPT+S | $74.49 | 73,433 | $5,470,024 | 664 |
| 2021-03-30 01:53 | 2021-03-26 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director | OPT+S | $74.73 | 270,650 | $20,225,675 | 524,026 |
| 2021-03-24 01:15 | 2021-03-19 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer | SELL | $74.15 | 49,211 | $3,648,996 | 18,226 |
| 2021-03-18 00:22 | 2021-03-16 | CVS | CVS HEALTH Corp | Boratto Eva C | Officer | OPT+S | $74.68 | 18,882 | $1,410,108 | 71,082 |
| 2021-02-18 01:04 | 2021-02-17 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | BUY | $72.00 | 3,000 | $216,000 | 14,334 |
| 2021-01-29 23:01 | 2021-01-29 | PETS | PETMED EXPRESS INC | FORMICA FRANK J | Director | SELL | $38.59 | 5,000 | $192,950 | 55,000 |
| 2021-01-29 20:17 | 2021-01-27 | PETS | PETMED EXPRESS INC | FULGONI GIAN | Director | SELL | $47.13 | 12,890 | $607,488 | 53,510 |
| 2021-01-29 00:57 | 2021-01-28 | PETS | PETMED EXPRESS INC | ROSENBLOOM BRUCE S | Officer | SELL | $50.00 | 5,000 | $250,000 | 36,525 |
| 2021-01-29 00:38 | 2021-01-27 | PETS | PETMED EXPRESS INC | AKDAG MENDERES | Director, Officer | SELL | $45.50 | 60,000 | $2,730,000 | 337,800 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Retail-Drug Stores and Proprietary Stores sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (5912) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Retail-Drug Stores and Proprietary Stores
Every transaction in the Retail-Drug Stores and Proprietary Stores industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.